About the Program:
Program Overview:
Despite significant advances in the treatment of people with HIV infection, professional practice gaps remain that contribute to continued morbidity and mortality. While clinical trials provide an evidence base regarding which ARV drugs and regimens are most likely to be effective for treating various patients, many HIV clinicians have not integrated them into their clinical practice. To address this problem, we have developed a case-based CME program that explores and analyzes current HIV treatment standards of care, including when to start, what to start in ARV-naive patients, and when to switch ARVs in virologically suppressed patients for the purpose of eliminating or avoiding toxicity, improving long-term patient health, or simplifying a regimen. Participants in this program will gain knowledge and skills that should lead to improved patient care.
Target Audience:
This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.
Learning Objectives:
Upon completion of the program, participants should be able to:
-
Initiate ARV therapy and provide individualized therapy to
patients with HIV infection that minimizes side effects and supports adherence
-
Identify and remove barriers to successful communications with
patients with HIV
-
Increase understanding and ability to safely switch patients to
newer antiretroviral agents to reduce side effects and/or pill burden
-
Provide effective treatment for HIV patients who are failing ARV
therapy
-
Provide individualized HIV care to minority patients that supports
adherence to ARV therapy
-
Effectively treat patients with HIV and co-morbid conditions
Release Date: August 31, 2018
Expiration Date: August 31, 2019
Estimated time to complete each Module: 30 minutes per indivitual moduels, 3 hours for "Play All" option
Media: Web
Faculty:
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of
Pennsylvania
Philadelphia, Pennsylvania
Wilbert Jordan, MD
Medical Director,
Charles Drew Medical Center
Los Angeles, California
Anthony Mills, MD
Southern California Men's Medical Group
Los Angeles, California
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Renslow Sherer, MD
Professor
of Medicin
Section
of Infectious Diseases and Global Health
University
of Chicago
Chicago,
Illinois
Back to Top
Accreditation Statement:
This activity has been planned and
implemented in accordance with the accreditation requirements and policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the
joint providership of the Annenberg Center for Health Sciences at Eisenhower
and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is
accredited by the ACCME to provide continuing medical education for physicians.
|
Back to Top
Credit Designation:
Module 1 (
Initiate Therapy to
Patients with HIV that Minimizes Side Effects and Supports Adherence):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 2 (Identify and Remove
Barriers to Successful Communications with HIV-Positive Patients):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 3 (Effectively Treat
HIV-Positive Patients and Co-morbid Conditions):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 4 (Switching ART to
Reduce Side-Effects and/or Pill Burden):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 5 (Provide Effective
Treatment for HIV-Positive Patients who are Failing ARV Therapy):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 6 (Provide
Individualized HIV Care to Minority Patients that Supports Adherence to ARV
Therapy):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Play All Option:
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Back to Top
Disclosure of Conflicts of Interest:
The Annenberg Center for Health Sciences
at Eisenhower requires instructors, planners, managers and other individuals
who are in a position to control the content of this activity to disclose any
real or apparent conflict of interest (COI) they may have as related to the
content of this activity. All identified COI are thoroughly vetted and resolved
according to the Annenberg Center for Health Sciences at Eisenhower
policy. The Annenberg Center for Health
Sciences at Eisenhower is committed to providing its learners with high quality
CME activities and related materials that promote improvements or quality in
healthcare and not a specific proprietary business interest of a commercial
interest.
The faculty reported the following
financial relationships or relationships they or their spouse/life partner have
with commercial interests related to the content of this continuing education
activity:
Ian Frank, MD
•Consulting
Fees: Gilead
•Contracted Research: ViiV/GlaxoSmithKline
Wilbert Jordan, MD:
•No
real or apparent conflicts to disclose
Anthony Mills, MD
•Consulting
Fees: Gilead, ViiV,
Merck
•Fees
for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead
•Contracted Research: Gilead, ViiV,
Merck
Paul Sax, MD:
•Consulting
Fees: AbbVie, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV,
Janssen, Merck
•Contacted
Research: NIH, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline/ViiV,
Merck
•Other
(Editorial Boards): Medscape, UpToDate, Open Forum Infectious Diseases
Renslow Sherer, MD:
•Consulting
fees: Gilead
The PIM planners and
managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi
Smelker-Mitchek, MBA, MSN, RN, and Amanda Glazar, PhD, CHCP have nothing to disclose.
Charles E. Willis,
Director of Continuing Education from the Annenberg Center for Health Sciences
at Eisenhower consults for Pfizer, Inc; Amanda Sewell, MBA, Manager of
Continuing Education and Alma Perez, Accreditation Specialist from the Annenberg
Center for Health Sciences at Eisenhower have no relevant commercial
relationships to disclose.
Back to Top
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this activity. During the period, August 31, 2018 through August 31, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If
you wish to received acknowledgment of completing this activity, please
complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 13490. Upon registering and successfully completing the post-test with a
score of 70% or better and the activity evaluation, your certificate
will be made available immediately. Processing credit requests online
will reduce the amount of paper used by nearly 100,000 sheets per year.
Back to Top
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or
investigational uses of agents that are not indicated by the FDA. The
planners of this activity do not recommend the use of any agent outside
of the labeled indications.
The opinions expressed in the educational activity are those of the
faculty and do not necessarily represent the views of the planners.
Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications, and warnings.
Back to Top
Disclaimer
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not meant to
serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed or
suggested in this activity should not be used by clinicians without
evaluation of their patient's conditions and possible contraindications
on dangers in use, review of any applicable manufacturer's product
information, and comparison with recommendations of other authorities.
Back to Top
Computer System Requirements
This
program requires a modern web browser (Internet Explorer 7+, Mozilla
Firefox, Apple Safari, Google Chrome). Certain educational activities
may require additional software to view multimedia, presentation, or
printable version of their content. These activities will be marked as
such and will provide links to the required software. That software may
be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint,
Windows Media Player and Real Networks Real One Player.
Back to Top
This activity is supported by an independent educational grant from ViiV Healthcare
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc., in collaboration with Postgraduate Institute for Medicine.
|